Details of Bacterial Vaccine
This bacterial vaccine card gives comprehensive information about each vaccine.
| Detailed Information | |
|---|---|
| ID | 1198 |
| Name of the vaccine | SC599 |
| Microbe | Bacteria |
| Disease name | Bacillary Dysentery (Shigellosis) |
| Name of bacteria | Shigella genus |
| Type of vaccine | Live attenuated |
| Nucleic acid content | DNA |
| Age | 18 to 50 years |
| Description of the vaccine | Shigella dysenteriae type-1 vaccine. |
| Name of the manufacturer | Institut Pasteur |
| Name of the manufacturing country | France, United Kingdom |
| Year of manufacture | 2007 |
| Clinical Phase status | Clinical - Phase 2 |
| Bacterial strain | Gram-negative bacteria. |
| Efficacy | NA |
| Vaccine formulation | NA |
| Dosage | Two doses. |
| Mechanism of action | IgA and IgG LPS-specific ASCs and antibody response. |
| Route of administration | Oral |
| Indications | NA |
| Export | NA |
| Approval | NA |
| Adjuvant | NA |
| Repurposing | NA |
| Side effects of vaccine | Mainly digestive effects. |
| Post vaccination | NA |
| Dose type | Combination doses |
| Interspecies transfer | NA |
| PubMed identifier | 19135496 |
| Clinical trial number | NCT00210288 |
| Reference | NA |
| Other name | NA |
| Additional Links | NA |